Arvin K. George, MD, presented “Complications of Focal Therapy – Risk Factors, Timepoints, Management​” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.

This content is available free to the GRU Community. Login or create an account to view it.


Create an Account

How to cite: George, Arvin K. Complications of Focal Therapy – Risk Factors, Timepoints, Management.” November, 2023. Accessed Jul 2024.

Complications of Focal Therapy – Risk Factors, Timepoints, Management – Summary

Arvin K. George, MD, examines common complications from the use of focal therapy to treat prostate cancer and explores management strategies. In this presentation, he discusses the causes and management strategies for possible complications resulting from focal therapy, including: 

  • Continence
  • Erectile and Sexual Dysfunction
  • Prostatic Abscesses
  • Rectourethral Fistulas
  • Urethral Sloughing
  • Urethral Strictures
  • Urinary Retention
  • Venous Thromboembolisms

Dr. George concludes by comparing the risks and benefits of focal therapy to those of HIFU and Cryoablation. He holds a Q+A session with the audience after his initial presentation.

Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies. 


Arvin George, MD, serves as Director of Prostate Cancer Programs and Associate Professor (PAR) of Urology at Johns Hopkins School of Medicine in Baltimore, Maryland. He is a urologic surgeon who specializes in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his urology residency at the Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine. He remained there to complete his endourology fellowship in New York, gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a urologic oncology fellowship at the National Cancer Institute of the National Institutes of Health. Dr. George’s research interests include minimally-invasive and image-guided treatments, functional prostate imaging, and focal therapy for prostate cancer. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer, including active surveillance and selection/treatment of patients with novel focal therapy modalities.